JUNE Medical Unveils the Galaxy II™ Slider

The most versatile surgical retractor on the market (040-21)

JUNE Medical, an award-winning medical device distributor renowned for its game-changing self-retaining retractors, is launching the Galaxy II Slider – the most versatile retractor yet.

The Galaxy II Slider is the world’s first adjustable self-retaining retractor to feature a sliding mechanism that allows surgeons to adjust the size to fit the width of the wound in situ. This makes the Galaxy II Slider an ideal solution for retracting tissue in narrow or hard to access operation sites, such as during hand surgeries, pediatrics, or procedures on patients with a high BMI.

JUNE Medical is committed to providing products that surgeons find valuable and developed the Galaxy II Slider in response to reports that standard size retractors may be more challenging to use on smaller anatomies, such as pediatric patients, or for patients with higher BMIs. The lightweight, self-retaining retractor weighs just 62 g and includes the revolutionary Cam lock system that allows for single-handed adjustment of the frame into position, and a sliding mechanism that can be securely locked into place at the correct width. This unique sliding mechanism allows surgeons to increase or decrease the tension to further separate the tissue while the surgical stay is in position, avoiding the need to reposition hooks, saving precious surgical time, and resulting in fewer skin punctures.

Rianne Mahanta, Product Manager of JUNE Medical, commented: “JUNE is proud to launch the first-ever self-retaining retractor with an adjustable sliding mechanism. This product is not only a fantastic addition to our Galaxy II range but is addressing real-world surgical problems. Although originally developed for narrow operating sites, the Galaxy II Slider is flexible and can be applied to a number of operations from hand surgeries to pediatrics.”

Angela Spang, CEO of JUNE Medical, added: “The Galaxy II Slider is another huge step for JUNE, demonstrating of our continual commitment to driving innovation and supplying functional products that are both practical and beneficial. This product is suitable for surgeries in any place, any shape, and any position, making it truly the most versatile retractor available.”

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.